Opentrons

Brooklyn, United States Founded: 2013 • Age: 13 yrs Unicorn
Pipetting robots for laboratory automation are developed.

About Opentrons

Opentrons is a company based in Brooklyn (United States) founded in 2013. Opentrons has raised $260.68 million across 7 funding rounds from investors including SoftBank Group, Khosla Ventures and Lerer Hippeau. Opentrons has completed 3 acquisitions, including Zenify, Zenith AI and Zenith Algorithm. Opentrons offers products and services including Opentrons Flex, Opentrons Flex Prep, OT-2 Workstations, and Pipettes and Modules. Opentrons operates in a competitive market with competitors including Tecan, Andrew Alliance, LabCyte, Ginolis and Scienion, among others.

  • Headquarter Brooklyn, United States
  • Stage Unicorn
  • Sectors
    Healthcare
    Industrial Goods & Manufacturing
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website opentrons.com
  • Social LinkedIn X Facebook Instagram YouTube
  • Legal Name Opentrons Labworks Inc.
Key Metrics
  • Total Equity Funding
    $260.68M (USD)

    in 7 rounds

  • Latest Funding Round
    $20.12M (USD), Series C

    Nov 2025

  • Investors
  • Investments & Acquisitions
    Zenify

    & 2 more

Products & Services of Opentrons

Opentrons offers a comprehensive portfolio of products and services, including Opentrons Flex, Opentrons Flex Prep, OT-2 Workstations, and Pipettes and Modules.

Opentrons Flex
Lab Robot

Modular robot for automating lab workflows and scientific protocols

Opentrons Flex Prep
Lab Workstation

System for quick pipetting and sample preparation tasks

OT-2 Workstations
Automation Platform

Workstation for NGS and proteomics applications

Pipettes and Modules
Lab Accessories

Components for precise liquid handling in research

Apps and channels of Opentrons

its YouTube channel Opentrons Robotics has 1.59K subscribers and 30 videos.

Opentrons Robotics
YouTube 1.59K subscribers 30 videos Science & Technology
Open channel

Videos from Opentrons

The most watched videos on Opentrons's YouTube channel, Opentrons Robotics (1.59K subscribers). Click a video to play it here.

The Opentrons Flex Proteomics Workstation & Plate Reader
52.1K views
Opentrons Flex: The future of lab automation is here
42.7K views
Introducing the Opentrons Flex Prep
29.9K views
The Opentrons Flex High-Throughput NGS Workstation
29.5K views

More on Opentrons Robotics.

Funding Insights of Opentrons

Opentrons has successfully raised a total of $260.68M across 7 strategic funding rounds. The most recent funding activity was a Series C round of $20.12 million completed in November 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $260.68M
  • Total Rounds 7
  • Last Round Series C β€” $20.12M
  • Investors Count 8

All 7 funding rounds of Opentrons with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Nov 2025$20.12MSeries C––
–
Sep 2021$200MSeries C$1.8BSoftBank Group
Aug 2020$20.6MSeries B––
–
Nov 2019$2.25MSeed––
–
Mar 2018$10.55MSeed–Khosla Ventures
Mar 2017$7.16MSeed––
–
Nov 2014–Seed–HAX
–
Valuation history
DateValuationStage
Sep 2021$1.8Bβ€’β€’β€’β€’β€’β€’β€’β€’

Last known valuation $1.8B (Sep 2021). 8 investors in total: 7 institutional and 1 angel.

Investors in Opentrons

Opentrons has secured backing from 8 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include SoftBank Group, Khosla Ventures and Lerer Hippeau.

All
Venture Fund
Institutional
Angel
InvestorDescriptionFounded YearDomainLocation
Early-stage startups are funded by this venture capital firm.
2004khoslaventures.comMenlo Park, United States
USA focused VC firm investing in seed and early stage startups
2010lererhippeau.comNew York, United States
Venture capital and accelerator services are provided across multiple sectors.
–sosv.comCork, Ireland
Early-stage startups are accelerated via funding and educational programs.
–ycombinator.comMountain View, United States
Startups are accelerated via a 111-day program with seed funding.
–hax.coSan Francisco, United States
Investments are directed toward multiple sectors via fund of funds.
1981group.softbankMinato City, Japan
Active, long-term growth equity investments are provided globally.
–sandscapital.comArlington, United States

Jeffrey B Kindler

Former Pfizer CEO, angel investor, and advisor in healthcare and tech.
–unknown_2f6d4bd67c6d481ab-
Premium access

Investor details for Opentrons

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Opentrons

42 people are tracked at Opentrons (17 in leadership, 25 in team).

NameRoleGroup
Jonathan Brennan-Badal
CEOLeadership
Greg Greeley
COOLeadership
Jonathan Badal
CEOLeadership
Kevan Savage
VP Marketing, RoboticsLeadership
Norma (Fuertes) Prus
Director, Human Resources Business PartnerLeadership
Cjuneyt "CJ" Ener
Head of StrategyLeadership
Meghan Ferzoco
Senior Director of Enterprise SalesLeadership
Vaishali H.
Director of Laboratory OperationsLeadership
Censia Pottorf
Global Executive Head of Human ResourcesLeadership
Kinnari Watson PhD
Scientific DirectorLeadership
Vince Dou
General Manager of ChinaLeadership
Boris Mindzak
Vice President, LegalLeadership
Derek Corson
Director; Consumer Sales Division (DTC) at OPENTRONSLeadership
Scott Hraska
Director Of OperationsLeadership
Danielle Tillman
Associate Director Of Total RewardsLeadership
Ben Donohue
VP of SoftwareLeadership
Greg Brown
VP of SalesLeadership
Samantha Falcone
Automation Sales ExecutiveTeam
Jordan H.
Outside Sales RepresentativeTeam
Kenneth H.
Global Payroll Operations ManagerTeam

22 more people are available in the full profile.

Premium access

Complete people profiles for Opentrons

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Opentrons

Opentrons has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Zenify, Zenith AI and Zenith Algorithm.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Cloud migration services are provided to facilitate infrastructure transitions.
zenith.ai–2017Oct 2021β€’β€’β€’β€’
Provider of an AI-assisted platform for the analysis of omics data
zenify.aiHolywood, United Kingdom2020Oct 2021β€’β€’β€’β€’
AI application development services are provided for the biopharma sector.
zenithai.co.ukBelfast, United Kingdom2020Oct 2021β€’β€’β€’β€’
Premium access

Complete acquisition details for Opentrons

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Opentrons

7 dated milestones of Opentrons across 12 years, from founding to its latest funding, stage changes and deals.

  1. Founded Opentrons is founded.
  2. Funding First funding round.
  3. Milestone Reaches Unicorn status.
  4. Acquisition Acquires Zenith AI.
  5. Acquisition Acquires Zenify.
  6. Acquisition Acquires Zenith Algorithm.
  7. Funding Latest funding round, Series C, of $20.1M.

Competitors of Opentrons

Opentrons operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Tecan, Andrew Alliance, LabCyte, Ginolis and Scienion, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
tecan.com1980Mannedorf, Switzerland––
Automated laboratory instruments, robotics, and diagnostic solutions are provided.
andrewalliance.com2011Vernier, Switzerland$14.03M5
Provider of automated liquid handling tools and software for scientific labs
labcyte.com2000Sunnyvale, United States$33.39M184
Acoustic liquid handling is developed for life science research.
ginolis.com2010Oulunsalo, Finland$2.41M–
Liquid handling and lab automation robots
scienion.com2000Berlin, Germany$5.67M114
Non-contact dispensing solutions for genomics and proteomics are provided.
alphasip.es2008Zaragoza, Spain––
Nanotube-based biosensor chips are produced for real-time medical diagnostics.
flow-robotics.com2015Copenhagen, Denmark$17.15M16
AI-based robots for laboratory liquid handling automation are provided.
reseatech.ch2015Burgdorf, Switzerland––
Fluid handling systems for biotechnology are manufactured and supplied.
biotix.com2005San Diego, United States$4.2M61
Laboratory consumables and liquid handling solutions
Premium access

Detailed competitors of Opentrons

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Opentrons

The website of Opentrons (opentrons.com) receives about 51.5K visits a month.

  • Monthly visits
    51.5K

    ▲ 14.6% vs previous month

Similar websites

Websites whose visitors overlap most with Opentrons. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
dispendix.com
100%
34.1K#1,043,639View details
thelabworldgroup.com
98%
–#998,297View details
integra-biosciences.com
98%
–#432,153View details
protocol-online.org
91%
–#777,385View details
idtdna.com
90%
505.8K#85,096View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 20 similar websites and full traffic analytics for Opentrons

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 20 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Latest news on Opentrons

Premium access

Complete news archive for Opentrons

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to Opentrons

10 companies that operate in the same segment as Opentrons (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
1999New York, New York, United StatesUSD 41.5 M––
AI-based solutions for health management are provided.
2015Dallas, Texas, United StatesUSD 2.8 B––
Nanopore-based electronic systems for single-molecule analysis are developed.
2005Oxford, Oxfordshire, United KingdomUSD 1.3 BUSD 301.49 M1,480
Real-world health data is provided for research and decisions.
2012Menlo Park, California, United StatesUSD 259.16 M––
Genetically modified cell lines are developed using AAV gene-editing platform.
2007Cambridge, Cambridgeshire, United KingdomUSD 46.29 M––
Biological reagents and antibodies are developed for life science research.
1998Cambridge, Cambridgeshire, United KingdomUSD 78.8 M––
Electron microscopy services and microanalysis instruments are provided.
1956Waltham, Massachusetts, United States–USD 44.56 B125,000
Novel therapeutics are discovered using an AI-enabled drug platform.
2013New York, New York, United StatesUSD 456.66 MUSD 74.68 M–
A platform for sharing and accessing academic research papers is provided.
2008San Francisco, California, United StatesUSD 58.4 M––
Developer of molecular diagnostic testing solutions
1996Sunnyvale, California, United StatesUSD 19.1 MUSD 54.88 M208
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Opentrons

Opentrons was founded in 2013 and raised its 1st funding round 1 year after it was founded.

Opentrons is headquartered in Brooklyn, United States. It is registered at Brooklyn, New York, United States.

Jonathan Brennan-Badal is the current CEO of Opentrons.

Opentrons is a funded company, having raised a total of $260.68M across 7 funding rounds to date.

Opentrons was founded in 2013 in Brooklyn, United States, within the lab automation sector. The OT-2 personal pipetting robot is produced to automate repetitive benchwork, including fluid transfers via manual micro-pipettes. Scalable hardware and software solutions are offered, with development conducted in an open-source format to support various laboratory activities.

Opentrons's top competitors include Tecan, Andrew Alliance and Scienion.

Opentrons offers Opentrons Flex, Opentrons Flex Prep, OT-2 Workstations, and Pipettes and Modules.

Opentrons has made 3 acquisitions, including Zenify, Zenith AI, and Zenith Algorithm.

Opentrons has 8 investors. Key investors include SoftBank Group, Khosla Ventures, Lerer Hippeau, Sands Capital, and SOSV.

The valuation of Opentrons is $1.8B as of Sep 2021.

Opentrons operates through Opentrons Labworks Inc..

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available